Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1-2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study

Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1-2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study

Background: Omitting axillary lymph node dissection (ALND) is recommended for early-stage breast cancer patients with 1-2 sentinel lymph nodes (SLNs) macro-metastases and breast-conserving therapy. However, it is not safe for part of patients, so it is significant to find risk factors and develop a...

Full description

Bibliographic Details
Main Authors: Xiangyu WANG, Yinqi GAO, Xue YANG, Xiangyi KONG, Zixing WANG, Yi FANG, Jing WANG
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-06-01
Series:Iranian Journal of Public Health
Subjects:
Breast cancer;
Risk-factors;
Predictive model;
Macro-metastases;
Breast-conserving surgery
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/14639

Internet

https://ijph.tums.ac.ir/index.php/ijph/article/view/14639

Similar Items